These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38293034)

  • 21. Familial encephalopathy with neuroserpin inclusion bodies.
    Davis RL; Holohan PD; Shrimpton AE; Tatum AH; Daucher J; Collins GH; Todd R; Bradshaw C; Kent P; Feiglin D; Rosenbaum A; Yerby MS; Shaw CM; Lacbawan F; Lawrence DA
    Am J Pathol; 1999 Dec; 155(6):1901-13. PubMed ID: 10595921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol impairment contributes to neuroserpin aggregation.
    Giampietro C; Lionetti MC; Costantini G; Mutti F; Zapperi S; La Porta CA
    Sci Rep; 2017 Mar; 7():43669. PubMed ID: 28255164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies.
    Onda M; Belorgey D; Sharp LK; Lomas DA
    J Biol Chem; 2005 Apr; 280(14):13735-41. PubMed ID: 15664988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation-, aging-, and gene dosage-dependent accumulation of neuroserpin (G392E) in endoplasmic reticula and lysosomes of neurons in transgenic mice.
    Takasawa A; Kato I; Takasawa K; Ishii Y; Yoshida T; Shehata MH; Kawaguchi H; Mohafez OM; Sasahara M; Hiraga K
    J Biol Chem; 2008 Dec; 283(51):35606-13. PubMed ID: 18940798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive deficits associated with a recently reported familial neurodegenerative disease: familial encephalopathy with neuroserpin inclusion bodies.
    Bradshaw CB; Davis RL; Shrimpton AE; Holohan PD; Rea CB; Fieglin D; Kent P; Collins GH
    Arch Neurol; 2001 Sep; 58(9):1429-34. PubMed ID: 11559315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rat model of human FENIB (familial encephalopathy with neuroserpin inclusion bodies).
    Takano K; Kitao Y; Inagi R; Momoi T; Matsuyama T; Miyata T; Yoneda Y; Iso H; Stern DM; Hori O; Ogawa S
    Biochem Biophys Res Commun; 2006 Aug; 346(3):1040-7. PubMed ID: 16782060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroserpin: structure, function, physiology and pathology.
    D'Acunto E; Fra A; Visentin C; Manno M; Ricagno S; Galliciotti G; Miranda E
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6409-6430. PubMed ID: 34405255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial conformational diseases and dementias.
    Crowther DC
    Hum Mutat; 2002 Jul; 20(1):1-14. PubMed ID: 12112652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.
    Takehara S; Onda M; Zhang J; Nishiyama M; Yang X; Mikami B; Lomas DA
    J Mol Biol; 2009 Apr; 388(1):11-20. PubMed ID: 19285087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
    Belorgey D; Crowther DC; Mahadeva R; Lomas DA
    J Biol Chem; 2002 May; 277(19):17367-73. PubMed ID: 11880376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embelin as Lead Compound for New Neuroserpin Polymerization Inhibitors.
    Visentin C; Musso L; Broggini L; Bonato F; Russo R; Moriconi C; Bolognesi M; Miranda E; Dallavalle S; Passarella D; Ricagno S
    Life (Basel); 2020 Jul; 10(7):. PubMed ID: 32664592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation Tunes Neuroserpin Physiological and Pathological Properties.
    Visentin C; Broggini L; Sala BM; Russo R; Barbiroli A; Santambrogio C; Nonnis S; Dubnovitsky A; Bolognesi M; Miranda E; Achour A; Ricagno S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting conformational dynamics of β-sheet A and helix F with implications in neuroserpin inhibition and aggregation.
    Ansari S; Ray A; Ali MF; Bano S; Jairajpuri MA
    Int J Biol Macromol; 2021 Apr; 176():117-125. PubMed ID: 33516851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.
    Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH
    Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serpinopathies studying serpin polymerization in vivo.
    Irving JA; Ekeowa UI; Belorgey D; Haq I; Gooptu B; Miranda E; Pérez J; Roussel BD; Ordóñez A; Dalton LE; Thomas SE; Marciniak SJ; Parfrey H; Chilvers ER; Teckman JH; Alam S; Mahadeva R; Rashid ST; Vallier L; Lomas DA
    Methods Enzymol; 2011; 501():421-66. PubMed ID: 22078544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological disease.
    Godinez A; Rajput R; Chitranshi N; Gupta V; Basavarajappa D; Sharma S; You Y; Pushpitha K; Dhiman K; Mirzaei M; Graham S; Gupta V
    Cell Mol Life Sci; 2022 Mar; 79(3):172. PubMed ID: 35244780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strand 1A variant in neuroserpin shows increased aggregation and no loss of inhibition: implication in ameliorating polymerization to retain activity.
    Ansari S; Ahamad S; Khan AB; Fatima S; Ahmad T; Khan Y; Gupta D; Jairajpuri MA
    Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36408789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial dementia caused by polymerization of mutant neuroserpin.
    Davis RL; Shrimpton AE; Holohan PD; Bradshaw C; Feiglin D; Collins GH; Sonderegger P; Kinter J; Becker LM; Lacbawan F; Krasnewich D; Muenke M; Lawrence DA; Yerby MS; Shaw CM; Gooptu B; Elliott PR; Finch JT; Carrell RW; Lomas DA
    Nature; 1999 Sep; 401(6751):376-9. PubMed ID: 10517635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endoplasmic reticulum (ER)-associated degradation system regulates aggregation and degradation of mutant neuroserpin.
    Ying Z; Wang H; Fan H; Wang G
    J Biol Chem; 2011 Jun; 286(23):20835-44. PubMed ID: 21507957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.